1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.02%
Revenue growth above 1.5x ENPH's 1.99%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
19.50%
Positive gross profit growth while ENPH is negative. John Neff would see a clear operational edge over the competitor.
47.10%
Positive EBIT growth while ENPH is negative. John Neff might see a substantial edge in operational management.
47.10%
Operating income growth above 1.5x ENPH's 26.34%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
18.20%
Net income growth at 50-75% of ENPH's 24.63%. Martin Whitman would question fundamental disadvantages in expenses or demand.
14.29%
EPS growth at 50-75% of ENPH's 21.74%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
23.08%
Similar diluted EPS growth to ENPH's 22.73%. Walter Schloss might see standard sector or cyclical influences on both firms.
-4.47%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-6.70%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-740.28%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-250.83%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
1309.36%
10Y revenue/share CAGR above 1.5x ENPH's 20.31%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1309.36%
5Y revenue/share CAGR above 1.5x ENPH's 174.77%. David Dodd would look for consistent product or market expansions fueling outperformance.
1309.36%
Positive 3Y CAGR while ENPH is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-2660.50%
Negative 10Y OCF/share CAGR while ENPH stands at 176.50%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-2660.50%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-2660.50%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
220.80%
Below 50% of ENPH's 2178.31%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
220.80%
5Y net income/share CAGR 1.25-1.5x ENPH's 174.41%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
220.80%
Positive short-term CAGR while ENPH is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.44%
Firm’s AR is declining while ENPH shows 17.72%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-12.62%
Inventory is declining while ENPH stands at 20.13%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.21%
Similar asset growth to ENPH's 2.34%. Walter Schloss finds parallel expansions or investment rates.
7.35%
75-90% of ENPH's 9.32%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
No Data
No Data available this quarter, please select a different quarter.
1.10%
We increase R&D while ENPH cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-1.63%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.